Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 122

New insight into the neurobiological roots of being a ‘morning person’ or ‘night owl’

Human beings exhibit marked differences in habits, lifestyles and behavioral tendencies. One of these differences, known as chronotype, is the inclination to sleep and wake up early or alternatively to sleep and wake up late.

Changes in society, such as the introduction of portable devices and video streaming services, may have also influenced people’s behavioral patterns, offering them further distractions that could occupy their evenings or late nights. Yet past studies have found that sleeping and waking up late is often linked to a higher risk of being diagnosed with , such as depression and , as well as poorer physical health.

Understanding the neurobiological underpinnings of humans’ chronotypes, as well as the possible implications of being a so-called “morning person” or “night owl,” could thus be beneficial. Specifically, it could inform the development of lifestyle interventions or designed to promote healthy sleeping patterns.

Chimeric brain models can help bridge the gap between animal studies and human neurological disorders

A specialized model used by researchers is becoming a valuable tool for studying human brain development, diseases and potential treatments, according to a team of scientists at Rutgers University-New Brunswick.

Known as chimeric brain models, these laboratory tools provide a unique way to understand human brain functions in a living environment, which may lead to new and better therapies for , researchers said in a review article in Neuron.

Scientists create models by transplanting human brain cells culled from into the brains of animals such as mice, thereby creating a mix of human and animal brain cells in the same brain. This environment is closer to the complexity of a living human brain than what can be simulated in a petri dish study.

Electricity-generating bacteria’s survival strategy could reshape biotech and energy systems

A team led by Rice University bioscientist Caroline Ajo-Franklin has discovered how certain bacteria breathe by generating electricity, using a natural process that pushes electrons into their surroundings instead of breathing on oxygen.

The findings, published in Cell, could enable in clean energy and industrial biotechnology.

By identifying how these bacteria expel electrons externally, the researchers offer a glimpse into a previously hidden strategy of bacterial life. This work, which merges biology with electrochemistry, lays the groundwork for future technologies that harness the unique capabilities of these microscopic organisms.

Gene circuits enable more precise control of gene therapy

Many diseases are caused by a missing or defective copy of a single gene. For decades, scientists have been working on gene therapy treatments that could cure such diseases by delivering a new copy of the missing genes to the affected cells.

Despite those efforts, very few gene therapy treatments have been approved by the FDA. One of the challenges to developing these treatments has been achieving control over how much the new gene is expressed in cells — too little and it won’t succeed, too much and it could cause serious side effects.

To help achieve more precise control of gene therapy, MIT engineers have tuned and applied a control circuit that can keep expression levels within a target range. In human cells, they showed that they could use this method to deliver genes that could help treat diseases including fragile X syndrome, a disorder that leads to intellectual disability and other developmental problems.

Preventing Multimer Formation in Commonly Used Synthetic Biology PlasmidsClick to copy article linkArticle link copied!

A nice brief paper comparing plasmid multimer formation in different strains of bacteria and identifying conditions under which such multimer formation occurs minimally. #biotech #synbio

Scientists Discover Nature’s Secret to Healthy Longevity

Over the past several decades, human lifespan has steadily increased. However, this progress has also led to a growing proportion of the population suffering from age-related diseases such as cancer, neurodegenerative disorders, and diabetes. Extending both lifespan and healthspan, the period of life spent in good health, requires a deeper understanding of the biological mechanisms that promote healthy aging.

In the natural world, mammalian lifespans vary enormously, ranging from just 1 to 2 years in some rodents to more than a century in species.

A species is a group of living organisms that share a set of common characteristics and are able to breed and produce fertile offspring. The concept of a species is important in biology as it is used to classify and organize the diversity of life. There are different ways to define a species, but the most widely accepted one is the biological species concept, which defines a species as a group of organisms that can interbreed and produce viable offspring in nature. This definition is widely used in evolutionary biology and ecology to identify and classify living organisms.

Zinc-transporting protein contributes to aggressive growth of brain tumor, researchers find

In a study published Wednesday in the Proceedings of the National Academy of Sciences, University of Oklahoma researchers detail their discoveries about why the brain tumor glioblastoma is so aggressive. Their findings center on ZIP4, a protein that transports zinc throughout the body and sets off a cascade of events that drive tumor growth.

About half of all malignant brain tumors are glioblastomas, the deadliest form of brain cancer with a median survival rate of 14 months.

“Surgery for glioblastoma is very challenging, and patients almost always experience a relapse,” said the study’s senior author, Min Li, Ph.D., a professor of medicine, surgery and at the University of Oklahoma College of Medicine. “By better understanding why these brain tumors are so aggressive, we hope to open up paths for new treatments.”

Specialized Immune Cells Develop Memory to Target Ovarian Cancer

The immune system is comprised of two separate active arms of immunity to provide robust protection against disease. The two separate systems of immunity include the innate and adaptive immune responses. The innate immune system is the first on the scene when a pathogen enters the body. Different cells of this response include eosinophils, basophils, neutrophils, natural killer cells, macrophages, dendritic cells, and others. Once a pathogen is detected the innate immune system generates a generalized response to target a wide variety of diseases. The innate immune cells then relay detection of a foreign pathogen to the second level of immunity, the adaptive immune response. The second wave that fights off disease is more specific and includes T and B cells. The adaptive immune response is widely accepted as the stronger barrier of immunity because of its specificity and ability to mount a larger response. However, each work in concert with the other to elicit an optimal immune response and keep the body healthy.

Many different cells are involved in active immunity that help protect against infection. As a result, immunologists work to understand each cell’s impact on the immune system and how they function in the context of various pathologies. To activate the immune system during an infection or disease onset, immunotherapy is employed, which targets one or several immune cell types to redirect them to the infection. In particular, natural killer cells, are emerging as an optimal cell target for immunotherapy in ovarian cancer.

Natural killer cells are a type of white blood cell responsible for eliminating virus-infected cells and tumor cells. They secrete various molecules and proteins that signal a strong immune response. Additionally, they have been reported to develop immune memory, in which they can recognize previously encountered pathogen. These natural killer cells that develop immune memory are referred to as adaptive natural killer (aNK) cells. Scientists are working to understand more about these cell types and how they can be targeted for cancer immunotherapy.